PER levels greater than 1.2 ng/mL were associated with increased risk of EPS ( P < .02) and a slightly weaker treatment response that did not reach statistical significance.
← all excerpts
A review of a recently published guidelines' "strong recommendation" for therapeutic drug monitoring of olanzapine, haloperidol, perphenazine, and fluphenazine.
1
—
—